Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects
Eva Martínez‐Cáceres(Hospital Universitari Germans Trias i Pujol), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Narcı́s Barberà(Vall d'Hebron Hospital Universitari), Luís Brieva(Hebron University), Carmen Espejo(Universitat Autònoma de Barcelona), Miquel A. Barrau(Vall d'Hebron Hospital Universitari)
Cited by 73
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k